Inventor · disambiguated record
Laura M. Walker
Also filed as: WALKER LAURA · WALKER LAURA M · WALKER LAURA MAJORIE
27 granted patents·12 pending applications·46 citations·filing 2014–2025
95Inventor score
Files withADIMAB LLC12MAPP BIOPHARMACEUTICAL INC9ADAGIO THERAPEUTICS INC4MABLOC LLC3THERACLONE SCIENCES INC3
Top patents by PatentIndex Score
39 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0393US11192940B2Compounds specific to coronavirus S protein and uses thereofADAGIO THERAPEUTICS INC·Filed 2021·Granted Dec 7, 2021·10 cites·14 claims
- 0488US11312761B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Apr 26, 2022·3 cites·18 claims
- 0586US11479600B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Oct 25, 2022·2 cites·22 claims
- 0686US11414479B2Compounds specific to coronavirus S protein and uses thereofADAGIO THERAPEUTICS INC·Filed 2021·Granted Aug 16, 2022·1 cites·13 claims
- 0786US11220536B1Compounds specific to coronavirus S protein and uses thereofADAGIO THERAPEUTICS INC·Filed 2021·Granted Jan 11, 2022·1 cites·23 claims
- 0884US11725045B2Anti-respiratory syncytial virus antibodies, methods of their generation and useMAPP BIOPHARMACEUTICAL INC·Filed 2018·Granted Aug 15, 2023·2 cites·45 claims
- 0984US11407817B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 1084US11407816B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 1184US11390964B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2020·Granted Jul 19, 2022·1 cites·10 claims
- 1284US11254732B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 22, 2022·1 cites·9 claims
- 1384US11242379B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 1484US11242378B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 1583US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1682US11479598B2Anti-yellow fever antibodies, and methods of their generation and useMABLOC LLC·Filed 2020·Granted Oct 25, 2022·1 cites·14 claims
- 1781US12258679B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2022·Granted Mar 25, 2025·0 cites·16 claims
- 1881US12209117B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2022·Granted Jan 28, 2025·0 cites·18 claims
- 1980US11485775B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Nov 1, 2022·1 cites·9 claims
- 2079US12281156B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2022·Granted Apr 22, 2025·0 cites·15 claims
- 2179US12215141B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2022·Granted Feb 4, 2025·0 cites·10 claims
- 2279US12110319B2Anti-yellow fever virus antibodies, and methods of their generation and useMABLOC LLC·Filed 2023·Granted Oct 8, 2024·0 cites·17 claims
- 2379US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 2478US11542330B2Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2018·Granted Jan 3, 2023·1 cites·19 claims
- 2578US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 2676US10684289B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2014·Granted Jun 16, 2020·1 cites·10 claims
- 2774US2025388653A1Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2025·Application pending·0 cites
- 2873US2024228597A1Anti-respiratory syncytial virus antibodies, methods of their generation and useMAPP BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2971US2022153815A1Compounds specific to coronavirus s protein and uses thereofADAGIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3070US2023203135A1Anti-yellow fever virus antibodies, and methods of their generation and useMABLOC LLC·Filed 2022·Application pending·0 cites
- 3169US2023151097A1Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2022·Application pending·0 cites
- 3268US2025313612A1Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2025·Application pending·0 cites
- 3366US10836810B2Monoclonal antibodies and cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2018·Granted Nov 17, 2020·0 cites·9 claims
- 3463US2025223339A1Sars-cov2 antibodies and uses thereofINVIVYD INC·Filed 2023·Application pending·0 cites
- 3562US12116401B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useBILL & MELINDA GATES MEDICL RES INSTITUTE·Filed 2022·Granted Oct 15, 2024·0 cites·19 claims
- 3658US2023000979A1Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and useALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3755US2021355195A1Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and useALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3852US2025019449A1Anti-ccr8 agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3942US2016340415A1ANTIBODIES DIRECTED AGAINST THE LukGH (LukAB) TOXIN OF STAPHYLOCOCCUS AUREUS AND ANTIBODY SEQUENCESARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →